Who makes Tagitol V, Lo So, Readi-Cat 2?

Tagitol V, Lo So, Readi-Cat 2 is developed by London North West Healthcare NHS Trust.

What development phase is Tagitol V, Lo So, Readi-Cat 2 in?

Tagitol V, Lo So, Readi-Cat 2 is FDA-approved (marketed).

Last reviewed 2026-05-13 · How we verify

Tagitol V, Lo So, Readi-Cat 2

London North West Healthcare NHS Trust · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Tagitol V, Lo So, Readi-Cat 2
Sponsor	London North West Healthcare NHS Trust
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Optimisation and Performance of Reduced Preparation CT Colography (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tagitol V, Lo So, Readi-Cat 2 CI brief — competitive landscape report
Tagitol V, Lo So, Readi-Cat 2 updates RSS · CI watch RSS
London North West Healthcare NHS Trust portfolio CI